In connection with the implementation of the project titled “Development and advancement of an innovative solution – a generic drug from the group of GLP-1 receptor agonists in the treatment of type 2 diabetes”, funded from the state budget by the Medical Research Agency, Zakłady Farmaceutyczne Polpharma S.A., requested to submit a bid for purchase and delivery of packaging directly for technological trials.
Details of the price inquiry can be found in the documents attached below.